JPRN-UMIN000006470已完成未知
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetes - Dpp-4 Inhibitor And Basal insulin-Therapy (DIAB-therapy)
Jikei University School of Medicine Kashiwa Hospital0 个研究点目标入组 20 人开始时间: 2011年12月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with type 1diabetes (fasting C-peptide less than 0.5mg/dL) 2)Patients with severe ketosis, diabetic coma or precoma within 6 months 3)Patients with severe infections, before or after operation, or serious trauma . 4)Patients with exceeding the moderate renal impairment (sCr: male>=1.5mg/dl, female>=1.3mg/dl). 5)Patients receiving GLP-1 analog 6)Patients receiving oral glucose lowering drug without metformin, SU or pioglitazone 7)Patients who are pregnant, breast-feeding and/or intention to become pregnant 8)Patients with allergy against sitagliptin 9)Other patients determined to be inappropriate by physician
研究者
相似试验
已完成
不适用
Effect of DPP-4 inhibitor or Metformin on insulin therapy in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000008155Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine40
已完成
不适用
In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safetyJPRN-UMIN000009908Diabetes Center,Tokyo Women's Medical University50
已完成
不适用
Insulin combined with the DPP-4 inhibitor sitagliptin for diabetes: evaluation studyType2 diabetesJPRN-UMIN000011346Japan Association for Diabetes Education and Care10,000
已完成
2 期
The effect of sitaglibtin (DPP4 inhibitor) administration in type 2 diabetes patients under insulin therapy regarding the weight, Lipid profile changes and blood glucose controlIRCT20191231045959N2Tabriz University of Medical Sciences60
进行中（未招募）
不适用
ANTIDIABETIC EFFECTS OF ADDING A DPP-4 INHIBITOR (SITAGLIPTIN) TO PRE-EXISTING TREATMENT WITH AN INCRETIN MIMETIC (LIRAGLUTIDE) IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH METFORMITYPE 2 DIABETESMedDRA version: 16.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-001764-35-DEDiabeteszentrum Bad Lauterberg